Autistic Disorder: Clinical Trials

22 trials for Autistic Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 4 unknown, 3 recruiting, 1 terminated. 22 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 422Completed 14, Unknown 4, Recruiting 3, Terminated 1

Follow Autistic Disorder: new trials by email Literature Review of Autistic Disorder trials Research Report on Autistic Disorder

Trials (filtered) newest first · largest first

All 22 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Buspirone for Anxiety in Autistic Youth
buspirone, Placebo - Anxiety, Autism Spectrum Disorder
Phase 4RecruitingMassachusetts General Hospital202026-09-012026-09-17
The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine
Adderall XR (mixed salts amphetamine), Placebo - Attention Deficit Hyperactivity Disorder (ADHD), Autism
Phase 4RecruitingGagan Joshi1962026-02-012026-03-06
AWARE: Management of ADHD in Autism Spectrum Disorder
Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant. - ADHD, Autism Spectrum Disorder
Phase 4RecruitingDaniel Coury5002023-10-012026-10-22
Intranasal Dexmedetomidine vs Oral Triclofos Sodium for EEG in Children With Autism
Dexmedetomidine, Triclofos 100 MG/ML - Autistic Disorder
Phase 4UnknownRabin Medical Center2002020-03-012020-02-17
A Study of Glutathione in Children With Autism Spectrum Disorder
Glutathione - Autism Spectrum Disorder
Phase 4TerminatedUniversity of Chicago62019-07-012025-09-18
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
Open-label Treatment with Omega-3 Fatty Acids + Inositol, Open-label Treatment with N-acetylcysteine - Non-verbal Learning Disorder, Autism Spectrum Disorder
Phase 4CompletedMassachusetts General Hospital542019-05-202025-06-05
Promoting Positive Outcomes for Individuals With ASD: Linking Early Detection, Treatment, and Long-term Outcomes
Enhanced early detection - Autism Spectrum Disorder
Phase 4CompletedDrexel University20872017-11-292024-08-16
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
Very Low Dose Quillivant XR, Low Dose Quillivant XR, Moderate Dose Quillivant XR - ADHD, Autism
Phase 4CompletedSeattle Children's Hospital362014-09-012017-08-01
Study to Evaluate the Efficacy and Safety of Aripiprazole
Aripiprazole - Autism
Phase 4UnknownYoo-Sook Joung792014-02-012014-03-11
Multisite Study: Parental Training Using Video Modelling to Develop Social Skills in Children With Autism
ABA parent training - Autism Spectrum Disorders
Phase 4CompletedFederal University of São Paulo672014-02-012015-04-02
An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum
Gammaplex 5% - Autism, Autistic Disorder
Phase 4UnknownIsaac Melamed302013-06-012015-04-16
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
placebo, extended-release guanfacine - Pervasive Development Disorders
Phase 4CompletedYale University622011-12-012020-03-31
Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
Aripiprazole, Risperidone - Autistic Disorder
Phase 4CompletedMedical University of South Carolina802011-07-012018-09-26
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Milnacipran, Placebo - Autism Spectrum Disorder, Asperger Syndrome
Phase 4CompletedMontefiore Medical Center102011-02-012020-02-27
Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders
Acetyl-Choline Esterase Inhibitors and Choline supplements, Indistinguishable placebo tablets, matching both donepezil and choline - Autism
Phase 4UnknownSheba Medical Center842010-03-012016-10-14
A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Risperidone, Other atypical antipsychotic drugs - Schizophrenia, Bipolar Disorder
Phase 4CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.2442009-10-012012-11-27
FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders
Aripiprazole - Autism Spectrum Disorder
Phase 4CompletedUniversity of North Carolina, Chapel Hill132009-08-012014-03-11
Atomoxetine, Placebo and Parent Management Training in Autism
atomoxetine, Placebo, Parent Management Training - Autism, Pervasive Development Disorder
Phase 4CompletedUniversity of Rochester1282008-10-012016-02-04
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Placebo, Risperidone high dose, Risperidone low dose - Autistic Disorder, Autism
Phase 4CompletedJohnson & Johnson Pharmaceutical Research & Development, L.L.C.962007-12-012014-05-09
Minocycline to Treat Childhood Regressive Autism
Minocycline - Autism, Minocycline
Phase 4CompletedNational Institute of Mental Health (NIMH)112006-11-012015-12-11

Showing 20 of 22. Sign in to see all of them.

Narrower conditions

Autism Spectrum Disorder (9)  ·  Attention Deficit Disorder with Hyperactivity (6)  ·  Asperger Syndrome (4)  ·  Child Development Disorders, Pervasive (3)  ·  Aggression (1)  ·  Anxiety Disorders (1)  ·  Behavior (1)  ·  Bipolar Disorder (1)  ·  Compulsive Behavior (1)  ·  Learning Disabilities (1)  ·  Schizophrenia (1)  ·  Spasm (1)  ·  cyclopia sequence (1)

Broader conditions

Mental Disorders (22)  ·  Neurodevelopmental Disorders (22)  ·  Child Development Disorders, Pervasive (19)  ·  Autism Spectrum Disorder (13)  ·  Attention Deficit and Disruptive Behavior Disorders (6)  ·  Behavior (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavioral Symptoms (1)  ·  Bipolar and Related Disorders (1)  ·  Communication Disorders (1)  ·  Impulsive Behavior (1)

Interventions

Aripiprazole (3)  ·  Risperidone (3)  ·  Atomoxetine Hydrochloride (2)  ·  Methylphenidate (2)  ·  5,10-dihydro-5-methylphenazine (1)  ·  Acetylcysteine (1)  ·  Adenosine Monophosphate (1)  ·  Buspirone (1)  ·  Choline (1)  ·  Dexmedetomidine (1)  ·  Fatty Acids, Omega-3 (1)  ·  Glutathione (1)  ·  Guanfacine (1)  ·  Inositol (1)  ·  Milnacipran (1)

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  Massachusetts General Hospital (2)  ·  Montefiore Medical Center (2)  ·  Daniel Coury (1)  ·  Drexel University (1)  ·  Eli Lilly and Company (1)  ·  Federal University of São Paulo (1)  ·  Gagan Joshi (1)  ·  Isaac Melamed (1)  ·  Medical University of South Carolina (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Rabin Medical Center (1)  ·  Seattle Children's Hospital (1)  ·  Sheba Medical Center (1)  ·  University of Chicago (1)

Countries

United States (17)  ·  Netherlands (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Greece (1)  ·  Israel (1)  ·  Philippines (1)  ·  Poland (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Eric Hollander, MD (2)  ·  Benjamin Handen, PhD (1)  ·  Bryan King, MD (1)  ·  C. Lindsay DeVane, Pharm.D. (1)  ·  Cheryl O Alderman, BS (1)  ·  Christopher McDougle, MD (1)  ·  Daniel Coury, MD (1)  ·  Diana Robins, PhD (1)  ·  Dorit Ben-Shalom, Ph.D (1)  ·  Gabriel Dichter, PhD (1)  ·  Gagan Joshi, MD (1)  ·  Isaac Melamed, MD (1)  ·  James Dziura, MPH, PhD (1)

Results publications

PMID 37811711, PMID 12472704, PMID 20377705, PMID 21318594, PMID 22704249, PMID 22721596, PMID 23212807, PMID 23566357, PMID 23578015, PMID 24018545, PMID 24350813, PMID 24532346, PMID 24823763, PMID 25019647, PMID 25246305, PMID 25369243, PMID 26231264, PMID 26506581, PMID 26814037, PMID 26936022, PMID 27663942, PMID 28347608, PMID 28455770, PMID 29022125, PMID 29694241, PMID 29701730, PMID 30982953, PMID 31063671, PMID 31292919, PMID 31447530, PMID 31862730, PMID 33934719, PMID 36112116, PMID 36808953, PMID 3706808, PMID 37267443, PMID 39454668, PMID 8632499, PMID 9060867

NIH funding

K23MH081285 (1), R01MH083707 (1)